Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-26,701
Closed -$311K 157
2024
Q1
$311K Sell
26,701
-17,505
-40% -$194K 0.03% 169
2023
Q4
$494K Buy
44,206
+16,341
+59% +$150K 0.06% 100
2023
Q3
$430K Buy
27,865
+4,340
+18% +$72.9K 0.05% 103
2023
Q2
$446K Buy
+23,525
New +$413K 0.08% 106

Other funds holding ETNB

Parkwood LLC's ETNB Position: Q2 2024 in Review

Parkwood LLC sold out of 89bio (ETNB) in Q2 2024, closing a stake of 26,701 shares — an estimated $311K sold.

Parkwood LLC first reported a position in ETNB in Q2 2023 and held it in 4 quarters. The position peaked at $494K in Q4 2023. 145 funds tracked by Wall St. Rank hold ETNB as of Q2 2024.

  • Parkwood LLC reported no remaining 89bio position as of Q2 2024 after selling out during the quarter.
  • Parkwood LLC sold 26,701 89bio shares in Q2 2024, an estimated $311K.
  • Parkwood LLC first reported a position in 89bio in Q2 2023 and held it in 4 quarters.
  • Parkwood LLC's 89bio position peaked at $494K in Q4 2023.
  • 145 funds tracked by Wall St. Rank held 89bio as of Q2 2024.

Based on Parkwood LLC's 13F filing for Q2 2024, filed 14 Aug 2024.